EUVIMEDEUVIMED entdecken
Crossref

Switching the Chemoselectivity in the Preparation of [ 18 F]FNA- N -CooP, a Free Thiol-Containing Peptide for Targeted Positron Emission Tomography Imaging of Fatty Acid Binding Protein 3

Pyry Dillemuth, Petter Lövdahl, Tuomas Karskela, Abiodun Ayo, Jesse Ponkamo, Heidi Liljenbäck iD, Sami Paunonen iD, Jonne Kunnas, Johan Rajander iD, Olli Tynninen, Jessica M Rosenholm iD, Anne Roivainen und 3 weitere

Molecular Pharmaceutics · 2024

DOI: 10.1021/acs.molpharmaceut.4c00546 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Pharmaceutics, 2024. Verfasst von Pyry Dillemuth und 14 weiteren Autor:innen. Beteiligte Einrichtung: Turku PET Centre, University of Turku, Kiinamyllynkatu 4-8, Turku FI-20520, Finland. Hauptthemen laut MEDLINE: Breast Neoplasms, Positron-Emission Tomography, Fatty Acid Binding Protein 3, Brain Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 20 Literaturangaben. Gefördert von: Sigrid Jus?liuksen S??ti?, Turun Yliopistos??ti?, Research Council of Finland.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Fatty acid binding protein 3 (FABP3) is expressed both in tumor cells and in the tumor vasculature, making it a potential target for medical imaging and therapy. In this study, we aimed to radiolabel a CooP peptide with a free amino and thiol group, and evaluate the radiolabeled product [18F]FNA-N-CooP for imaging FABP3 expression in breast cancer brain metastases by positron emission tomography. [18F]FNA-N-CooP was prepared by highly chemoselective N-acylation and characterized using different chemical approaches. We validated its binding to the target using in vitro tissue section autoradiography and performed stability tests in vitro and in vivo. [18F]FNA-N-CooP was successfully synthesized in 16.8% decay-corrected radiochemical yield with high radiochemical purity (98.5%). It exhibited heterogeneous binding on brain metastasis tissue sections from a patient with breast cancer, with foci of radioactivity binding corresponding to FABP3 positivity. Furthermore, the tracer binding was reduced by 55% in the presence of nonradioactive FNA-N-CooP a blocker, indicating specific tracer binding and that FABP3 is a viable target for [18F]FNA-N-CooP. Favorably, the tracer did not bind to necrotic tumor tissue. However, [18F]FNA-N-CooP displayed limited stability both in vitro in mouse plasma or human serum and in vivo in mouse, therefore further studies are needed to improve the stability [18F]FNA-N-CooP to be used for in vivo applications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsPositron-Emission TomographyFatty Acid Binding Protein 3Brain NeoplasmsFluorine RadioisotopesRadiopharmaceuticalsAnimalsHumansFemaleMiceCell Line, TumorPeptidesTissue DistributionSulfhydryl CompoundsMice, Nude

Stichwörter der Autor:innen

18F-labelingCooP peptideautoradiographybrain metastasisfatty acid binding protein 3positron emission tomography

Substanzen

Fatty Acid Binding Protein 3Fluorine RadioisotopesRadiopharmaceuticalsPeptidesFABP3 protein, humanSulfhydryl Compounds

Autor:innen und Institutionen

  • Turku PET Centre, University of Turku, Kiinamyllynkatu 4-8, Turku FI-20520, Finland.
  • Department of Chemistry, University of Turku, Henrikinkatu 2, Turku FI-20500, Finland.
  • Pharmaceutical Sciences Laboratory, Faculty of Science and Engineering, Åbo Akademi University, Tykistökatu 6, Turku FI-20520, Finland.
  • Turku Centre for Chemical and Molecular Analytics, Åbo Akademi University and University of Turku, Henrikinkatu 2, Turku FI-20500, Finland.
  • Translational Cancer Medicine Research Program, Faculty of Medicine, University of Helsinki, Haartmaninkatu 4, Helsinki FI-00290, Finland.
  • Turku Center for Disease Modeling, University of Turku, Kiinamyllynkatu 10, Turku FI-20520, Finland.

ORCID-Profile: Heidi Liljenbäck, Sami Paunonen, Johan Rajander, Jessica M Rosenholm, Pirjo Laakkonen, Anu J Airaksinen, Xiang-Guo Li

Förderung

  • Sigrid Jus?liuksen S??ti?
  • Turun Yliopistos??ti?
  • Research Council of Finland
  • Sy?p?s??ti?
  • Turun Yliopistollinen Keskussairaala
  • Suomen Kulttuurirahasto

Zitieren

APA

Dillemuth, P., Lövdahl, P., Karskela, T., Ayo, A., Ponkamo, J., Liljenbäck, H., Paunonen, S., Kunnas, J., Rajander, J., Tynninen, O., Rosenholm, J. M., Roivainen, A., Laakkonen, P., Airaksinen, A. J., & Li, X. G. (2024). Switching the Chemoselectivity in the Preparation of [ 18 F]FNA- N -CooP, a Free Thiol-Containing Peptide for Targeted Positron Emission Tomography Imaging of Fatty Acid Binding Protein 3. Molecular Pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.4c00546

Vancouver

Dillemuth P, Lövdahl P, Karskela T, Ayo A, Ponkamo J, Liljenbäck H, et al. Switching the Chemoselectivity in the Preparation of [ 18 F]FNA- N -CooP, a Free Thiol-Containing Peptide for Targeted Positron Emission Tomography Imaging of Fatty Acid Binding Protein 3. Molecular Pharmaceutics. 2024. doi:10.1021/acs.molpharmaceut.4c00546

BibTeX
@article{Dillemuth2024,
  author = {Dillemuth, Pyry and Lövdahl, Petter and Karskela, Tuomas and Ayo, Abiodun and Ponkamo, Jesse and Liljenbäck, Heidi and Paunonen, Sami and Kunnas, Jonne and Rajander, Johan and Tynninen, Olli and Rosenholm, Jessica M and Roivainen, Anne and Laakkonen, Pirjo and Airaksinen, Anu J and Li, Xiang-Guo},
  title = {Switching the Chemoselectivity in the Preparation of [ 18 F]FNA- N -CooP, a Free Thiol-Containing Peptide for Targeted Positron Emission Tomography Imaging of Fatty Acid Binding Protein 3},
  journal = {Molecular Pharmaceutics},
  year = {2024},
  doi = {10.1021/acs.molpharmaceut.4c00546}
}
Kostenlos starten →